DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
10.52
-0.43 (-3.93%)
At close: Nov 14, 2025, 4:00 PM EST
10.60
+0.08 (0.76%)
After-hours: Nov 14, 2025, 7:21 PM EST
DENTSPLY SIRONA Stock Forecast
Stock Price Forecast
The 11 analysts that cover DENTSPLY SIRONA stock have a consensus rating of "Hold" and an average price target of $17.09, which forecasts a 62.45% increase in the stock price over the next year. The lowest target is $12 and the highest is $23.
Price Target: $17.09 (+62.45%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for DENTSPLY SIRONA stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 9 | 8 | 9 | 9 | 9 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $18 → $14 | Buy | Maintains | $18 → $14 | +33.08% | Nov 10, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +14.07% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +14.07% | Nov 7, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 7, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $18 | Buy | Maintains | $18 | +71.10% | Oct 29, 2025 |
Financial Forecast
Revenue This Year
3.73B
from 3.79B
Decreased by -1.77%
Revenue Next Year
3.78B
from 3.73B
Increased by 1.45%
EPS This Year
1.92
from -4.48
EPS Next Year
2.06
from 1.92
Increased by 7.49%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.9B | 4.0B | |||
| Avg | 3.7B | 3.8B | |||
| Low | 3.5B | 3.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.9% | 6.5% | |||
| Avg | -1.8% | 1.4% | |||
| Low | -6.5% | -10.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.04 | 2.42 | |||
| Avg | 1.92 | 2.06 | |||
| Low | 1.77 | 1.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 26.1% | |||
| Avg | - | 7.5% | |||
| Low | - | -1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.